Prof G Markets: Nvidia’s Blowout Earnings & Stock Split + Britain’s Damaged Economy
The Prof G Pod with Scott Galloway
The GLP-1 Drug Market and BuzzFeed's Stake
This chapter explores the implications of a new, cheaper GLP-1 drug entering the market without FDA approval, questioning the sustainability of this model amid ongoing drug shortages. It also critiques the pharmaceutical industry's focus on profits over consumer well-being and discusses a questionable investment in BuzzFeed, setting the stage for an analysis of NVIDIA's earnings.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
